On Friday, Evolus Inc (NASDAQ: EOLS) opened lower -4.31% from the last session, before settling in for the closing price of $14.62. Price fluctuations for EOLS have ranged from $9.25 to $17.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 55.81% over the last five years. Company’s average yearly earnings per share was noted 41.84% at the time writing. With a float of $55.93 million, this company’s outstanding shares have now reached $63.25 million.
The firm has a total of 273 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.25%, operating margin of -13.69%, and the pretax margin is -22.2%.
Evolus Inc (EOLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Evolus Inc is 11.70%, while institutional ownership is 82.35%. The most recent insider transaction that took place on Dec 23 ’24, was worth 24,438. In this transaction an insider of this company sold 2,252 shares at a rate of $10.85, taking the stock ownership to the 366,595 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Financial Officer sold 1,586 for $10.85, making the entire transaction worth $17,211. This insider now owns 146,916 shares in total.
Evolus Inc (EOLS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.84% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Check out the current performance indicators for Evolus Inc (EOLS). In the past quarter, the stock posted a quick ratio of 2.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.01 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Analysing the last 5-days average volume posted by the [Evolus Inc, EOLS], we can find that recorded value of 0.6 million was lower than the volume posted last year of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 39.13%. Additionally, its Average True Range was 0.84.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 55.31%, which indicates a significant increase from 27.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.44% in the past 14 days, which was lower than the 66.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.39, while its 200-day Moving Average is $13.48. Now, the first resistance to watch is $14.58. This is followed by the second major resistance level at $15.17. The third major resistance level sits at $15.57. If the price goes on to break the first support level at $13.60, it is likely to go to the next support level at $13.20. Now, if the price goes above the second support level, the third support stands at $12.61.
Evolus Inc (NASDAQ: EOLS) Key Stats
There are currently 63,321K shares outstanding in the company with a market cap of 885.87 million. Presently, the company’s annual sales total 202,090 K according to its annual income of -61,690 K. Last quarter, the company’s sales amounted to 61,090 K and its income totaled -19,170 K.
